{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:07:44Z","timestamp":1793311664952,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NCTU-KMU-109-IF-01"],"award-info":[{"award-number":["NCTU-KMU-109-IF-01"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST109-2320-B-009-003-MY3"],"award-info":[{"award-number":["MOST109-2320-B-009-003-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST109-2320-B-009-004-MY3"],"award-info":[{"award-number":["MOST109-2320-B-009-004-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bcp.2022.115289","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T03:22:32Z","timestamp":1665544952000},"page":"115289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Co-inhibition of Aurora A and Haspin kinases enhances survivin blockage and p53 induction for mitotic catastrophe and apoptosis in human colorectal cancer"],"prefix":"10.1016","volume":"206","author":[{"given":"Chien-I","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zan-Chu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Hsuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Chia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Tai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Man","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Che","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rou-Hsin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Yuh","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuh-Jyh","family":"Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-I","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2022.115289_b0005","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.bcp.2022.115289_b0010","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.bcp.2022.115289_b0015","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMra040958","article-title":"Systemic therapy for colorectal cancer","volume":"352","author":"Meyerhardt","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bcp.2022.115289_b0020","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1158\/2159-8290.CD-20-1531","article-title":"Rational Treatment of Metastatic Colorectal Cancer: A Reverse Tale of Men Mice, and Culture Dishes","volume":"11","author":"Avolio","year":"2021","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.bcp.2022.115289_b0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/35048096","article-title":"Mitotic kinases as regulators of cell division and its checkpoints","volume":"2","author":"Nigg","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.bcp.2022.115289_b0030","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.molcel.2013.10.002","article-title":"Autoinhibition and Polo-dependent multisite phosphorylation restrict activity of the histone H3 kinase Haspin to mitosis","volume":"52","author":"Ghenoiu","year":"2013","journal-title":"Mol. Cell"},{"issue":"6001","key":"10.1016\/j.bcp.2022.115289_b0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1126\/science.1189505","article-title":"Survivin reads phosphorylated histone H3 threonine 3 to activate the mitotic kinase Aurora B","volume":"330","author":"Kelly","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bcp.2022.115289_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110303","article-title":"Roles and regulation of Haspin kinase and its impact on carcinogenesis","volume":"93","author":"Quadri","year":"2022","journal-title":"Cell. Signal."},{"issue":"10","key":"10.1016\/j.bcp.2022.115289_b0045","doi-asserted-by":"crossref","first-page":"e21923","DOI":"10.1096\/fj.202100099R","article-title":"Loss of haspin suppresses cancer cell proliferation by interfering with cell cycle progression at multiple stages","volume":"35","author":"Wang","year":"2021","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.bcp.2022.115289_b0050","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.drudis.2017.10.005","article-title":"Haspin: a promising target for the design of inhibitors as potent anticancer drugs","volume":"23","author":"Amoussou","year":"2018","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bcp.2022.115289_b0055","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bioorg.2018.03.031","article-title":"3H-pyrazolo[4,3-f]quinoline haspin kinase inhibitors and anticancer properties","volume":"78","author":"Opoku-Temeng","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2022.115289_b0060","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1083\/jcb.201205106","article-title":"Haspin inhibitors reveal centromeric functions of Aurora B in chromosome segregation","volume":"199","author":"Wang","year":"2012","journal-title":"J. Cell Biol."},{"issue":"11","key":"10.1016\/j.bcp.2022.115289_b0065","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/onc.2011.335","article-title":"Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin","volume":"31","author":"Huertas","year":"2012","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bcp.2022.115289_b0070","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrc1526","article-title":"Aurora-A - a guardian of poles","volume":"5","author":"Marumoto","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.bcp.2022.115289_b0075","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nrc1502","article-title":"Aurora-kinase inhibitors as anticancer agents","volume":"4","author":"Keen","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.bcp.2022.115289_b0080","first-page":"2705","article-title":"The role of Aurora-A in human cancers and future therapeutics","volume":"10","author":"Lin","year":"2020","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.bcp.2022.115289_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113495","article-title":"Aurora kinase inhibitors as potential anticancer agents: Recent advances","volume":"221","author":"Pradhan","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2022.115289_b0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/ng1220","article-title":"Identification of Stk6\/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human","volume":"34","author":"Ewart-Toland","year":"2003","journal-title":"Nat. Genet."},{"issue":"14","key":"10.1016\/j.bcp.2022.115289_b0095","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1038\/s41388-021-01711-x","article-title":"Aurora-A kinase oncogenic signaling mediates TGF-beta-induced triple-negative breast cancer plasticity and chemoresistance","volume":"40","author":"Jalalirad","year":"2021","journal-title":"Oncogene"},{"issue":"19","key":"10.1016\/j.bcp.2022.115289_b0100","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1038\/s41388-022-02293-y","article-title":"Aurora kinase A inhibition induces synthetic lethality in SMAD4-deficient colorectal cancer cells via spindle assembly checkpoint activation","volume":"41","author":"Shi","year":"2022","journal-title":"Oncogene"},{"issue":"59","key":"10.1016\/j.bcp.2022.115289_b0105","doi-asserted-by":"crossref","first-page":"7691","DOI":"10.1038\/sj.onc.1209754","article-title":"Phospho-regulation of human protein kinase Aurora-A: analysis using anti-phospho-Thr288 monoclonal antibodies","volume":"25","author":"Ohashi","year":"2006","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bcp.2022.115289_b0110","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/med.20203","article-title":"Biology of Aurora A kinase: implications in cancer manifestation and therapy","volume":"31","author":"Karthigeyan","year":"2011","journal-title":"Med. Res. Rev."},{"issue":"21","key":"10.1016\/j.bcp.2022.115289_b0115","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1158\/1078-0432.CCR-11-3251","article-title":"Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study","volume":"18","author":"Mosse","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2022.115289_b0120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jtho.2019.10.013","article-title":"C.s. investigators, Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses","volume":"15","author":"Owonikoko","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"10","key":"10.1016\/j.bcp.2022.115289_b0125","doi-asserted-by":"crossref","first-page":"e1457","DOI":"10.1634\/theoncologist.2020-0610","article-title":"A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma","volume":"25","author":"Gay","year":"2020","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.bcp.2022.115289_b0130","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1016\/S2352-3026(19)30203-0","article-title":"Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial","volume":"7","author":"Brunner","year":"2020","journal-title":"Lancet Haematol"},{"issue":"9","key":"10.1016\/j.bcp.2022.115289_b0135","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1074\/jbc.M311732200","article-title":"Regulation of p53 stability and function in HCT116 colon cancer cells","volume":"279","author":"Kaeser","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bcp.2022.115289_b0140","first-page":"1888","article-title":"Expression of survivin and p53 modulates honokiol-induced apoptosis in colorectal cancer cells","volume":"115","author":"Lai","year":"2014","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2022.115289_b0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cbi.2008.07.012","article-title":"Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells","volume":"176","author":"Liu","year":"2008","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.bcp.2022.115289_b0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.toxlet.2006.08.018","article-title":"Opposing securin and p53 protein expression in the oxaliplatin-induced cytotoxicity of human colorectal cancer cells","volume":"167","author":"Chiu","year":"2006","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.bcp.2022.115289_b0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/toxsci\/kfj070","article-title":"Depletion of securin increases arsenite-induced chromosome instability and apoptosis via a p53-independent pathway","volume":"90","author":"Chao","year":"2006","journal-title":"Toxicol. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2022.115289_b0160","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.4161\/cbt.12.12.18141","article-title":"Aurora A mediates cross-talk between N- and C-terminal post-translational modifications of p53","volume":"12","author":"Warnock","year":"2011","journal-title":"Cancer Biol. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2022.115289_b0165","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s12276-021-00635-6","article-title":"Aurora kinase A, a synthetic lethal target for precision cancer medicine","volume":"53","author":"Mou","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.bcp.2022.115289_b0170","doi-asserted-by":"crossref","first-page":"e1002566","DOI":"10.1371\/journal.ppat.1002566","article-title":"Kaposi's sarcoma herpesvirus upregulates Aurora A expression to promote p53 phosphorylation and ubiquitylation","volume":"8","author":"Cai","year":"2012","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.bcp.2022.115289_b0175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng1279","article-title":"Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53","volume":"36","author":"Katayama","year":"2004","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.bcp.2022.115289_b0180","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm0897-917","article-title":"A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma","volume":"3","author":"Ambrosini","year":"1997","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.bcp.2022.115289_b0185","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s12015-020-09995-4","article-title":"Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics","volume":"16","author":"Warrier","year":"2020","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"10.1016\/j.bcp.2022.115289_b0190","first-page":"43","article-title":"Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation","volume":"152","author":"Adida","year":"1998","journal-title":"Am. J. Pathol."},{"issue":"6711","key":"10.1016\/j.bcp.2022.115289_b0195","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/25141","article-title":"Control of apoptosis and mitotic spindle checkpoint by survivin","volume":"396","author":"Li","year":"1998","journal-title":"Nature"},{"issue":"53","key":"10.1016\/j.bcp.2022.115289_b0200","doi-asserted-by":"crossref","first-page":"55875","DOI":"10.1074\/jbc.M407985200","article-title":"Survivin and p53 modulate quercetin-induced cell growth inhibition and apoptosis in human lung carcinoma cells","volume":"279","author":"Kuo","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.bcp.2022.115289_b0205","doi-asserted-by":"crossref","first-page":"20267","DOI":"10.1074\/jbc.M312381200","article-title":"Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells","volume":"279","author":"Chao","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2022.115289_b0210","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.cdd.4401416","article-title":"Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L\/TRAIL-induced apoptosis","volume":"11","author":"Chawla-Sarkar","year":"2004","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.bcp.2022.115289_b0215","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bcp.2005.05.028","article-title":"Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells","volume":"70","author":"Lin","year":"2005","journal-title":"Biochem. Pharmacol."},{"issue":"16","key":"10.1016\/j.bcp.2022.115289_b0220","doi-asserted-by":"crossref","first-page":"14329","DOI":"10.18632\/oncotarget.3685","article-title":"JAK2 inhibitor TG101348 overcomes erlotinib-resistance in non-small cell lung carcinoma cells with mutated EGF receptor","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2022.115289_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114792","article-title":"A novel EGFR inhibitor suppresses survivin expression and tumor growth in human gefitinib-resistant EGFR-wild type and -T790M non-small cell lung cancer","volume":"193","author":"Wang","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115289_b0230","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.taap.2007.04.007","article-title":"Activation of p38 mitogen-activated protein kinase by celecoxib oppositely regulates survivin and gamma-H2AX in human colorectal cancer cells","volume":"222","author":"Hsiao","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2022.115289_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052622","article-title":"TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues","volume":"22","author":"Bartha","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2022.115289_b0240","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00412-009-0250-4","article-title":"Haspin: a newly discovered regulator of mitotic chromosome behavior","volume":"119","author":"Higgins","year":"2010","journal-title":"Chromosoma"},{"issue":"25","key":"10.1016\/j.bcp.2022.115289_b0245","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1182\/blood-2009-12-259523","article-title":"A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma","volume":"115","author":"Gorgun","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bcp.2022.115289_b0250","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1023\/A:1023789416385","article-title":"The Aurora kinases: role in cell transformation and tumorigenesis","volume":"22","author":"Katayama","year":"2003","journal-title":"Cancer Metastasis Rev."},{"issue":"6001","key":"10.1016\/j.bcp.2022.115289_b0255","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1126\/science.1189435","article-title":"Histone H3 Thr-3 phosphorylation by Haspin positions Aurora B at centromeres in mitosis","volume":"330","author":"Wang","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bcp.2022.115289_b0260","doi-asserted-by":"crossref","first-page":"16049","DOI":"10.1038\/celldisc.2016.49","article-title":"Aurora-A promotes the establishment of spindle assembly checkpoint by priming the Haspin-Aurora-B feedback loop in late G2 phase","volume":"3","author":"Yu","year":"2017","journal-title":"Cell Discov"},{"issue":"3","key":"10.1016\/j.bcp.2022.115289_b0265","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1158\/1535-7163.MCT-11-0623","article-title":"The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells","volume":"11","author":"Sehdev","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"7","key":"10.1016\/j.bcp.2022.115289_b0270","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bcp.2011.01.017","article-title":"Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma","volume":"81","author":"Qi","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2022.115289_b0275","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1083\/jcb.201105058","article-title":"Aurora A and Aurora B jointly coordinate chromosome segregation and anaphase microtubule dynamics","volume":"195","author":"Hegarat","year":"2011","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.bcp.2022.115289_b0280","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1101\/gad.1267105","article-title":"The kinase haspin is required for mitotic histone H3 Thr 3 phosphorylation and normal metaphase chromosome alignment","volume":"19","author":"Dai","year":"2005","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.bcp.2022.115289_b0285","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0092-8674(00)00034-9","article-title":"Mitotic phosphorylation of histone H3 is governed by Ipl1\/aurora kinase and Glc7\/PP1 phosphatase in budding yeast and nematodes","volume":"102","author":"Hsu","year":"2000","journal-title":"Cell"},{"issue":"6166","key":"10.1016\/j.bcp.2022.115289_b0290","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.1244508","article-title":"A cascade of histone modifications induces chromatin condensation in mitosis","volume":"343","author":"Wilkins","year":"2014","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bcp.2022.115289_b0295","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.tcb.2012.11.005","article-title":"Histone modifications and mitosis: countermarks, landmarks, and bookmarks","volume":"23","author":"Wang","year":"2013","journal-title":"Trends Cell Biol."},{"issue":"48","key":"10.1016\/j.bcp.2022.115289_b0300","doi-asserted-by":"crossref","first-page":"20198","DOI":"10.1073\/pnas.0901989106","article-title":"Structure and functional characterization of the atypical human kinase haspin","volume":"106","author":"Eswaran","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"3","key":"10.1016\/j.bcp.2022.115289_b0305","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/embr.201438472","article-title":"Plk1 puts a (Has)pin on the mitotic histone code","volume":"15","author":"Moutinho-Santos","year":"2014","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.bcp.2022.115289_b0310","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1535-6108(02)00235-0","article-title":"AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol","volume":"3","author":"Anand","year":"2003","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.bcp.2022.115289_b0315","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1083\/jcb.201205119","article-title":"A small-molecule inhibitor of Haspin alters the kinetochore functions of Aurora B","volume":"199","author":"De Antoni","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2022.115289_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128614","article-title":"A dual aurora and lim kinase inhibitor reduces glioblastoma proliferation and invasion","volume":"61","author":"Rybin","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bcp.2022.115289_b0325","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1021\/acs.jmedchem.1c01031","article-title":"Novel Aurora A and Protein Kinase C (alpha, beta1, beta2, and theta) Multitarget Inhibitors: Impact of Selenium Atoms on the Potency and Selectivity","volume":"65","author":"Bijian","year":"2022","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2022.115289_b0330","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cac2.12125","article-title":"CRISPR\/Cas9 screening identifies a kinetochore-microtubule dependent mechanism for Aurora-A inhibitor resistance in breast cancer","volume":"41","author":"Chen","year":"2021","journal-title":"Cancer Commun. (Lond)"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222003835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222003835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:15:17Z","timestamp":1762096517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295222003835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":66,"alternative-id":["S0006295222003835"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115289","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-inhibition of Aurora A and Haspin kinases enhances survivin blockage and p53 induction for mitotic catastrophe and apoptosis in human colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115289"}}